Orexigen Therapeutics Inc (OREX) financial statements (2021 and earlier)

Company profile

Business Address 3344 N. TORREY PINES CT.
LA JOLLA, CA 92037
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7187871047699127
Cash and cash equivalents46377792747868
Short-term investments2550101112159
Restricted cash and investments  4090165165115
Receivables19861233
Inventory, net of allowances, customer advances and progress billings16162123241115
Inventory16162123241115
Other undisclosed current assets7456643
Total current assets:112114159224273283262
Noncurrent Assets
Property, plant and equipment1111111
Intangible assets, net (including goodwill)7072747678  
Intangible assets, net (excluding goodwill)7072747678  
Prepaid expense     6060
Restricted cash and investments00000050
Other noncurrent assets0333311
Total noncurrent assets:717678808363113
TOTAL ASSETS:184190236305356345375
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities55394846411516
Accounts payable11816151245
Accrued liabilities44313230291111
Business combination, contingent consideration, liability   1514  
Deferred revenue and credits132521010
Other undisclosed current liabilities    9115
Total current liabilities:56424965653530
Noncurrent Liabilities
Liabilities, other than long-term debt15151413137880
Deferred revenue and credits766667880
Other liabilities     00
Business combination, contingent consideration, liability89876  
Total noncurrent liabilities:15151413137880
Total liabilities:7157647878113111
Stockholders' equity
Stockholders' equity attributable to parent(62)(42)(8)5773(10)11
Common stock0000000
Additional paid in capital711707704698696659657
Accumulated other comprehensive income (loss)(7)(4)24(2)(1)(3)
Accumulated deficit(766)(745)(714)(645)(621)(668)(643)
Total stockholders' equity:(62)(42)(8)5773(10)11
Other undisclosed liabilities and equity175175181170204243253
TOTAL LIABILITIES AND EQUITY:184190236305356345375

Income statement (P&L) ($ in millions)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
Revenues19231914785
Revenue, net19231914653
Cost of revenue
(Cost of Goods and Services Sold)
(4)(7)(6)(4)(2)(2) 
Gross profit:15171310565
Operating expenses(38)(59)(67)27(42)(39)(28)
Other undisclosed operating income (loss)   (79)79  
Operating income (loss):(23)(42)(54)(43)43(33)(23)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
211(15)18581
Interest and debt expense(1)(1)1224(2)(2)(2)
Income (loss) from continuing operations before equity method investments, income taxes:(22)(31)(57)(0)46(27)(24)
Other undisclosed loss from continuing operations before income taxes   (18)   
Income (loss) from continuing operations before income taxes:(22)(31)(57)(19)46(27)(24)
Other undisclosed loss from continuing operations   (0)   
Net income (loss):(22)(31)(57)(19)46(27)(24)
Other undisclosed net income (loss) attributable to parent11(12)(6)222
Net income (loss) available to common stockholders, diluted:(21)(31)(69)(25)48(25)(22)

Comprehensive Income ($ in millions)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
Net income (loss):(22)(31)(57)(19)46(27)(24)
Comprehensive income (loss):(22)(31)(57)(19)46(27)(24)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)(6)(14)(0)14(1)
Comprehensive income (loss), net of tax, attributable to parent:(24)(37)(71)(19)47(23)(25)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: